Sinohealth Technology Holdings Limited

As of December 31, 2025, Sinohealth Technology Holdings Limited carries a market capitalization of 2.22B, placing it among publicly traded companies globally. Its enterprise value stands at 1.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sinohealth Technology Holdings Limited's next confirmed earnings release is scheduled for March 26, 2027.

As of December 31, 2025, Sinohealth Technology Holdings Limited has 407.39M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Sinohealth Technology Holdings Limited maintains a current ratio of 7.21, meaning it holds 7.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 8, 2026, Sinohealth Technology Holdings Limited's stock has gained approximately 5.63% over the past 52 weeks. The 50-day moving average sits at 4.79, while the 200-day moving average is 4.60.

As of December 31, 2025, Sinohealth Technology Holdings Limited holds 698.79M in cash and equivalents against 8.86M in total debt, resulting in a net debt position of -259.66M. Total book value stands at 839.64M, with working capital of 736.19M providing operational flexibility.